학술논문
Clinical and virological outcomes with baloxavir compared with oseltamivir in pediatric patients aged 6 to
Document Type
article
Author
Source
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-10 (2021)
Subject
Language
English
ISSN
1471-2334
Abstract
Abstract Background Children with influenza virus infections are prone to complications and are common sources of influenza transmission. Baloxavir marboxil inhibits cap-dependent endonuclease and was approved for influenza treatment in adolescent, adult, and pediatric patients in Japan. The miniSTONE-2 study included pediatric patients with influenza (1 to